Shinichiro Uchiyama

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Hans‐Christoph Diener, Ralph L. Sacco, J. Donald Easton et al. · New England Journal of Medicine · 2019 · 811 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi et al. · Circulation Journal · 2012 · 638 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

Pierre Amarenco, Philippa C. Lavallée, Julien Labreuche et al. · New England Journal of Medicine · 2016 · 600 citations · Full text

Medicine, Neurology, Clinical Epidemiology +16

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Yukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama et al. · The Lancet Neurology · 2010 · 487 citations

Pharmacy, Neurology, Pharmacotherapy +10